BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombination.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 07 2021
Historique:
received: 22 01 2021
accepted: 12 07 2021
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 25 8 2021
Statut: epublish

Résumé

BRCA2 and its interactors are required for meiotic homologous recombination (HR) and fertility. Loss of HSF2BP, a BRCA2 interactor, disrupts HR during spermatogenesis. We test the model postulating that HSF2BP localizes BRCA2 to meiotic HR sites, by solving the crystal structure of the BRCA2 fragment in complex with dimeric armadillo domain (ARM) of HSF2BP and disrupting this interaction in a mouse model. This reveals a repeated 23 amino acid motif in BRCA2, each binding the same conserved surface of one ARM domain. In the complex, two BRCA2 fragments hold together two ARM dimers, through a large interface responsible for the nanomolar affinity - the strongest interaction involving BRCA2 measured so far. Deleting exon 12, encoding the first repeat, from mBrca2 disrupts BRCA2 binding to HSF2BP, but does not phenocopy HSF2BP loss. Thus, results herein suggest that the high-affinity oligomerization-inducing BRCA2-HSF2BP interaction is not required for RAD51 and DMC1 recombinase localization in meiotic HR.

Identifiants

pubmed: 34326328
doi: 10.1038/s41467-021-24871-6
pii: 10.1038/s41467-021-24871-6
pmc: PMC8322138
doi:

Substances chimiques

BRCA2 Protein 0
BRCA2 protein, human 0
Cell Cycle Proteins 0
HSF2BP protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4605

Informations de copyright

© 2021. The Author(s).

Références

Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4):a016600
pubmed: 25833843
Nat Commun. 2020 Apr 14;11(1):1819
pubmed: 32286328
J Biol Chem. 2012 Feb 10;287(7):5091-101
pubmed: 22187435
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19350-5
pubmed: 20974951
N Engl J Med. 2018 Sep 13;379(11):1042-1049
pubmed: 30207912
Plant Physiol. 2006 Mar;140(3):1059-69
pubmed: 16415210
Nat Methods. 2018 Nov;15(11):849-854
pubmed: 30377375
FEBS Lett. 2013 Jul 11;587(14):2099-104
pubmed: 23707421
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
Cell Death Dis. 2019 Jun 17;10(7):474
pubmed: 31209201
Gene. 1998 Jul 3;214(1-2):139-46
pubmed: 9651507
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Nature. 2002 Nov 21;420(6913):287-93
pubmed: 12442171
Mol Cell. 2006 Jun 23;22(6):719-729
pubmed: 16793542
Cell Mol Life Sci. 2017 Feb;74(3):525-541
pubmed: 27497926
Nucleic Acids Res. 2018 Jan 4;46(D1):D1266-D1270
pubmed: 29069414
Mol Cell. 2015 Jul 16;59(2):176-87
pubmed: 26145171
EMBO J. 2007 Jun 20;26(12):2915-22
pubmed: 17541404
EMBO J. 2002 Jun 3;21(11):2591-601
pubmed: 12032072
EMBO J. 2004 Mar 24;23(6):1392-401
pubmed: 15014444
Chromosome Res. 1997 Feb;5(1):66-8
pubmed: 9088645
PLoS Genet. 2016 Aug 04;12(8):e1006236
pubmed: 27490902
Cell Rep. 2019 Jun 25;27(13):3790-3798.e7
pubmed: 31242413
PLoS Genet. 2008 Feb;4(2):e31
pubmed: 18266476
Mol Cell Biol. 2005 Apr;25(8):3127-39
pubmed: 15798199
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Mar 1;63(Pt 3):204-8
pubmed: 17329815
Hum Mutat. 2008 Nov;29(11):1342-54
pubmed: 18951461
J Mol Biol. 2007 Sep 14;372(2):549-61
pubmed: 17681540
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Chromosoma. 2009 Apr;118(2):259-67
pubmed: 19034475
Nat Commun. 2020 Apr 28;11(1):2055
pubmed: 32345962
Hum Mutat. 2009 Nov;30(11):1543-50
pubmed: 19795481
PLoS Genet. 2009 Oct;5(10):e1000702
pubmed: 19851446
Nat Genet. 1997 Dec;17(4):423-30
pubmed: 9398843
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3515-20
pubmed: 26976601
Acta Crystallogr D Struct Biol. 2016 Apr;72(Pt 4):454-66
pubmed: 27050125
Cold Spring Harb Perspect Biol. 2014 Oct 09;6(12):a016451
pubmed: 25301930
Acta Crystallogr D Biol Crystallogr. 2011 Nov;67(Pt 11):915-9
pubmed: 22101817
Development. 2004 Jan;131(1):131-42
pubmed: 14660434
Nucleic Acids Res. 2020 Jul 9;48(12):6624-6639
pubmed: 32463460
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Cell Biol. 2020 Jun 1;219(6):
pubmed: 32346721
Nat Commun. 2019 Feb 13;10(1):722
pubmed: 30760716
Nucleic Acids Res. 2020 Mar 18;48(5):2442-2456
pubmed: 31960047
Mol Cell Biol. 1994 Feb;14(2):1137-46
pubmed: 8289794
J Genet Genomics. 2020 Aug;47(8):451-465
pubmed: 33250349
J Cell Biol. 2014 Dec 8;207(5):599-613
pubmed: 25488918
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Nucleic Acids Res. 2020 Sep 25;48(17):9649-9659
pubmed: 32785644
Nature. 1987 Mar 19-25;326(6110):292-5
pubmed: 3821905
EMBO Rep. 2009 Sep;10(9):990-6
pubmed: 19609323
Genesis. 2012 Jul;50(7):517-24
pubmed: 22266914
Nucleic Acids Res. 2017 May 5;45(8):4507-4518
pubmed: 28168276
Science. 2002 Sep 13;297(5588):1837-48
pubmed: 12228710
Cell Cycle. 2015;14(21):3389-95
pubmed: 26566862
Nat Commun. 2017 Jul 7;8(1):66
pubmed: 28687761
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1531-6
pubmed: 21205896
DNA Repair (Amst). 2002 Oct 1;1(10):779-93
pubmed: 12531026
Mol Cells. 2008 Dec 31;26(6):590-4
pubmed: 18779660
Structure. 2013 Oct 8;21(10):1735-42
pubmed: 24035711
Cell Rep. 2020 May 26;31(8):107686
pubmed: 32460033
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Elife. 2020 Aug 26;9:
pubmed: 32845237

Auteurs

Rania Ghouil (R)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Uni Paris-Sud, Uni Paris-Saclay, Gif-sur-Yvette, France.

Simona Miron (S)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Uni Paris-Sud, Uni Paris-Saclay, Gif-sur-Yvette, France.

Lieke Koornneef (L)

Department of Developmental Biology, Oncode Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Jasper Veerman (J)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Maarten W Paul (MW)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Marie-Hélène Le Du (MH)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Uni Paris-Sud, Uni Paris-Saclay, Gif-sur-Yvette, France.

Esther Sleddens-Linkels (E)

Department of Developmental Biology, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Sari E van Rossum-Fikkert (SE)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.
Department of Radiation Oncology, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Yvette van Loon (Y)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Natalia Felipe-Medina (N)

Molecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca), Salamanca, Spain.

Alberto M Pendas (AM)

Molecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca), Salamanca, Spain.

Alex Maas (A)

Department of Cell Biology, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Jeroen Essers (J)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.
Department of Radiation Oncology, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.
Department of Vascular Surgery, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Pierre Legrand (P)

Synchrotron SOLEIL, L'Orme des Merisiers, Gif-sur-Yvette, France.

Willy M Baarends (WM)

Department of Developmental Biology, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands.

Roland Kanaar (R)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands. r.kanaar@erasmusmc.nl.

Sophie Zinn-Justin (S)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Uni Paris-Sud, Uni Paris-Saclay, Gif-sur-Yvette, France. Sophie.ZINN@cea.fr.

Alex N Zelensky (AN)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA, Rotterdam, The Netherlands. a.zelensky@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH